FREDRIC N ESHELMAN
CIK 1033409 · Executive Chairman · last filed 2022-10-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$197.79M
Companies
7
Total Filings
114
Lifetime Open-Market Net
$26.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aravive, Inc. (ARAV) Delisted | Executive Chairman | 25,517,889 | $0.04 | $1.02M | $0 | 3 | 2022-10-26 |
| HYPERION DEFI, INC. (EYEN) Delisted | Director | 1,618,835 | $15.82 | $25.61M | $3.35M | 5 | 2021-11-22 |
| LQDA | 10%+ Owner | 2,776,783 | $71.23 | $197.79M | -$16.43M | 7 | 2021-01-27 |
| G1 Therapeutics, Inc. (GTHX) Delisted | Director | 3,689,151 | $7.15 | $26.38M | $9.43M | 6 | 2020-06-12 |
| MEDICINES CO /DE (MDCO) Delisted | Executive Chairman | 2,076,686 | — | — | $36.41M | 8 | 2018-06-04 |
| Furiex Pharmaceuticals, Inc. (FURX) Delisted | Director | 2,715,188 | — | — | $35.19M | 28 | 2013-07-02 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Executive Chairman | 0 | — | — | -$41.16M | 50 | 2011-12-06 |
Recent Filings · Page 8 of 12
114 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-03-01 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-12-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Other (J) | — | $0 | EDGAR |
| 2009-07-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Other (J) | — | $0 | EDGAR |
| 2009-05-22 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Gift (G) | −100,000 | $0 | EDGAR |
| 2009-02-20 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-11-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Mixed | −70,000 | $0 | EDGAR |
| 2008-08-29 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Gift (G) | −40,000 | $0 | EDGAR |
| 2008-08-08 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Gift (G) | −39,000 | $0 | EDGAR |
| 2008-05-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Sell (S) | −70,780 | -$3.03M | EDGAR |
| 2008-05-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Sell (S) | −79,220 | -$3.40M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.